Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Is Chewy Stock a Buy for 2022?
Is Chewy Stock a Buy for 2022?

Shares of Chewy (NYSE: CHWY) haven't kept up with the wider market's surge in 2021. That might be setting investors up for great long-term returns from here, though.

In this video from "Beat &amp

Why Peter Lynch Would Love Rocket
Why Peter Lynch Would Love Rocket

Famed investor Peter Lynch said that he loved great companies in lousy industries. The popular industries generally get thrown a lot of investment dollars, making it hard to make a buck. On the

My Favorite Social Media Stocks to Buy in 2022
My Favorite Social Media Stocks to Buy in 2022

Social media platforms are generally free to join and to use. The companies make money by showing advertisements to people browsing and interacting with the platforms. More users, interacting more

Ignore the Fed -- Investors Should Focus on This Surefire Strategy InsteadPhoto, wide shot, wide-angle lens,  Bank, sunset photo at golden hour, photo by Art Wolfe: https://img.theapi.app/temp/3aa597ca-f944-4a9b-bf8d-3071f3b5a5c9.png
Ignore the Fed -- Investors Should Focus on This Surefire Strategy Instead

It seems like lately, no other topic receives more attention from investors than what the Federal Reserve is going to do. 

How quickly should the central bank wind down its monthly bond purchases?

My Highest-Conviction Market Prediction for 2022
My Highest-Conviction Market Prediction for 2022

The year is almost over, and that means Wall Street strategists are revealing their top stock market predictions for the new year. Because their price targets are wrong nearly all of the time, I

How Many Vehicles Will Tesla Deliver in Q4?
How Many Vehicles Will Tesla Deliver in Q4?

With the first day of winter here, it's a good reminder of how close we are to many publicly traded companies closing out their fourth calendar quarters. For Tesla (NASDAQ: TSLA), these last 10 days

M&A Moves Are Lifting These 2 Stocks Tuesday Morning
M&A Moves Are Lifting These 2 Stocks Tuesday Morning

December's roller-coaster moves in the stock market have been hard to stomach, but at least investors have gotten periodic relief from sharp drops. It appeared that Tuesday would provide a bounce

4 Ways to Slash Your Expenses as a Retiree
4 Ways to Slash Your Expenses as a Retiree

Reaching retirement and finding out you don't have enough money can be devastating.

You don't want to take too much out of your retirement accounts too fast and jeopardize the chances of your money

Apple Delays Office Return Indefinitely: Are Office REITs Doomed?
Apple Delays Office Return Indefinitely: Are Office REITs Doomed?

For almost two years now, real estate investors have been losing sleep over the fate of office real estate investment trusts (REITs). With office buildings sitting empty in many major markets, the

1 Growing Small-Cap Company to Keep Your Eye On
1 Growing Small-Cap Company to Keep Your Eye On

In this segment of "Industry Focus" on Motley Fool Live, recorded on Dec. 2, Fool analysts Nick Sciple and Auri Hughes discuss the recent encouraging revenue numbers and acquisitions for XPEL

1 Top Supply Chain Stock to Consider Buying in 2022
1 Top Supply Chain Stock to Consider Buying in 2022

The global supply chain mess has been one of the biggest business stories of 2021. The pandemic has caused disruptions to the supply chains of many industries, hurting companies and consumers. 

Some

Will There Be a Metaverse Real Estate Boom in 2022?
Will There Be a Metaverse Real Estate Boom in 2022?

There's nothing buzzier right now than the metaverse, and nothing more intriguing to a lot of investors than virtual real estate. There are plenty of good reasons to be excited about the metaverse

3 Wildly Undervalued Stocks to Buy for 2022
3 Wildly Undervalued Stocks to Buy for 2022

Paint and coatings company Axalta Coating Systems (NYSE: AXTA), electrical products company nVent Electric (NYSE: NVT), and specialty chemicals distributor Univar Solutions (NYSE: UNVR) aren't

Why Shiba Inu Could Be Ready for a Bull Run in 2022
Why Shiba Inu Could Be Ready for a Bull Run in 2022

There's no question that Shiba Inu (CRYPTO: SHIB) has been one of the biggest winners of 2021. The dog-themed cryptocurrency is up a remarkable 45,000,000%, climbing from just 0.000000000073 at the

Where to Invest if You're Worried About Inflation
Where to Invest if You're Worried About Inflation

Turn on the financial news, and the single topic I'm certain you'll hear about first is rising consumer prices. The unexpected surge in consumer demand as the U.S. economy slowly opened back up

3 Top Stocks That Can Trounce Supply Chain Issues This Holiday Season
3 Top Stocks That Can Trounce Supply Chain Issues This Holiday Season

This year, the holidays are looking different. Last year, lots of people couldn't even leave their homes, but this year, gift-giving might be most affected. As we near the end of the gift-purchasing

The Top 3 REITs in Mobile Towers
The Top 3 REITs in Mobile Towers

Mobile communications have become as essential an underpinning of daily life as highways and power plants, and they can be expected to present infrastructure investment opportunities for years to

This Company Can Keep Your Car Looking New – Why One Analyst Loves Its Stock
This Company Can Keep Your Car Looking New – Why One Analyst Loves Its Stock

In this segment of "Industry Focus" on Motley Fool Live, recorded on Dec. 2, Fool analysts Auri Hughes and Nick Sciple chat about XPEL (NASDAQ: XPEL) and the unique business it has built. 

1 Great Stock to Own Whether the Stock Market Goes Up or Down
1 Great Stock to Own Whether the Stock Market Goes Up or Down

Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) is widely considered to be one of the most recession-resistant stocks in the market, and for good reason. Most of its subsidiaries are designed to

There's a 51% Chance of Your Retirement Plans Going Awry. Here's Why
There's a 51% Chance of Your Retirement Plans Going Awry. Here's Why

When you're making plans for retirement, you'll end up making some crucial assumptions in order to estimate the amount you should have invested for your future. Unfortunately, reality may not always

Will Coupang Be Worth More Than Amazon by 2030?
Will Coupang Be Worth More Than Amazon by 2030?

A lot of investors are looking for the next Amazon (NASDAQ: AMZN). With returns of 173,000% since its initial public offering and 1,776% returns over the last 10 years, long-term investors in the

3 Investors' Paths to Retirement Planning
3 Investors' Paths to Retirement Planning

It's never too early to start planning for retirement and build a stronger financial future. In this segment of Backstage Pass, recorded on Nov. 17, Fool contributors and investors Rachel Warren

Why This Merger Means Big Growth for This Apartment Stock
Why This Merger Means Big Growth for This Apartment Stock

Independence Realty Trust (NYSE: IRT), a multifamily real estate investment trust (REIT), has been anxiously awaiting the approval of the merger with Steadfast Apartment REIT. The company announced

2 Reasons to Sell Docebo StockPhoto, wide shot, wide-angle lens,  Consumer electronics manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://img.theapi.app/temp/d8a4268f-c982-4aa8-a09e-f9ee1db62f57.png
2 Reasons to Sell Docebo Stock

Docebo (NASDAQ: DCBO) is the latest artificial intelligence stock to catch my eye. The company is bringing a different strategy to the enterprise learning management system (LMS) space by focusing

Better Buy: Viatris vs. AbbViePhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Better Buy: Viatris vs. AbbVie

With a market cap of nearly $16 billion, the generic drugmaker Viatris (NASDAQ: VTRS) is minuscule in comparison to the profitable pharma titan AbbVie's (NYSE: ABBV) $228 billion. But, with Viatris'